Clinical Care


Diabetes in the young, school performance and KiDS

School is a vital part of life for children, who spend up to a third of their time in varying educational institutions from the age of 4 to 5 years through to young adulthood.

TB and diabetes: risks, management and improving outcomes

This World Tuberculosis (TB) Day, March 24 2016, the World Health Organization (WHO) is calling for renewed commitments and action in the global fight against TB – one of the world’s top infectious killers. While effective diagnosis and treatment of TB saved an estimated 43 million lives between 2000 and 2014, TB remains one of the world’s biggest threats, with 1.5 million people killed by the disease every year.

Hypoglycaemia, a global cause for concern

Hypoglycaemia in diabetes is often considered to be relevant only to those with type 1 diabetes T1D. Evidence has long been available that hypoglycaemia occurs in people with type 2 diabetes (T2D) using sulphonylureas.

Diabetic Foot Disease: When the alarm to action is missing

Did you know that every 20 seconds an amputation caused by diabetes occurs somewhere in the world? Paradoxically 85 percent of all amputations caused by diabetes are preventable. If amputation is almost always preventable then this is good news for people at greatest risk for diabetic foot disease. Sadly, amputations are still occurring at too great a rate in high, low- and middle-income countries.

For Jeffrey, diabetes education has made all the difference

It was 32ºC in the Capital city of Santo Domingo in the Dominican Republic on the day I met Jeffrey, who at 28 had lived with diabetes for 14 years. It was so hot at the Plaza de la Salud General Hospital that volunteers were giving bottles of water to visitors at the front entrance. Jeffrey and I had never met when he appeared in my office and I did not know why he had come for a consultation. He was wet with sweat from the heat outside and I noticed he was not wearing shoes.

Monitorización continua de glucosa (MCG) en entornos de recursos limitados

La monitorización continua de glucosa (MCG) es una tecnología relativamente nueva que tiene el potencial de ayudar a las personas que viven con diabetes tipo 1 o tipo 2 y son tratadas con insulina a lograr el objetivo de control óptimo de la glucemia.

Surveillance continue de la glycémie (SCG) dans des environnements limités en ressources

La surveillance continue de la glycémie (SCG) est une technologie relativement nouvelle qui pourrait aider les personnes atteintes de diabète de type 1 ou de type 2 sous insuline à atteindre l'objectif d'un contrôle optimal de leur glycémie.

Voces de la diabetes: ¿quién es tu principal apoyo?

Controlar la diabetes tipo 1 y la diabetes tipo 2 lleva mucho tiempo, es complejo y, con frecuencia, difícil. Frecuentemente se detectan síntomas de agotamiento debido al control diabético, ya que muchas personas se sienten a la vez sobrepasadas y vencidas por la diabetes, además de frustradas por la carga que supone el autocontrol diabético.

Continuous Glucose Monitoring (CGM) in resource limited settings

Continuous Glucose Monitoring (CGM) is a relatively new technology which has the potential to assist people living with type 1 or type 2 diabetes and treated with insulin to achieve the goal of optimum control of blood glucose.

The double burden of diabetes and TB - experience in India

At present, India is facing a dual epidemic of diabetes and tuberculosis (TB). In 2013, there were an estimated 65.1 million people with diabetes and the number is projected to rise to 109 million in 2035.1 Today it is estimated that 80% of all diabetes cases occur in low- and middle-income countries. People with diabetes (type 1 or type 2 diabetes) are at higher risk of contracting TB.